KFDA grants marketing authorization for Cialis tablet

The Korea Food and Drug Administration decided to approve Eli Lilly's Cialis tablet for the treatment of erectile dysfunction on July 29 on the condition that Lilly Korea should undertake its side-effects monitoring for six years and in case where this drug is to be proven as a drug of misuse or overuse hereafter, its marketing is subject to related provisions to be notified.

According to th...